We are live on
!
Find out more
VCM
Vision Capital Management Portfolio holdings
AUM
$792M
1-Year Est. Return
18.17%
This Fund
S&P 500
This Quarter
Est. Return
+13.03%
1 Year Est. Return
+18.17%
3 Year Est. Return
+56.41%
5 Year Est. Return
+57.55%
10 Year Est. Return
+256.21%
AUM
$360M
AUM Growth
+$42.3M
(+13%)
Cap. Flow
+$2.64M
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
48.07%
Holding
83
New
7
Increased
38
Reduced
28
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.29M |
| 2 |
Amgen
AMGN
|
+$1.51M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.29M |
| 4 |
F5
FFIV
|
+$1.26M |
| 5 |
AGN
Allergan plc
AGN
|
+$831K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$4.5M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.26M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.06M |
| 4 |
Starbucks
SBUX
|
+$872K |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$582K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.12% |
| 2 | Consumer Discretionary | 9.84% |
| 3 | Industrials | 7.61% |
| 4 | Financials | 7.56% |
| 5 | Communication Services | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $240K | 0.07% |
+2,763
| New | +$234K |
|
77
Meta Platforms (Facebook)
META
$1.49T
| $232K | 0.06% |
1,393
-200
| -13% | -$31.8K |
|
78
American States Water
AWR
$3.44B
| $230K | 0.06% |
3,221
| – | – |
|
79
Union Pacific
UNP
$174B
| $226K | 0.06% |
+1,353
| New | +$218K |
|
|
RPAI
80
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $194K | 0.05% |
15,942
| – | – |
|
|
81
AbbVie
ABBV
$465B
| – | – |
-48,863
| Closed | -$4.5M |
|
82
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| – | – |
-1,169
| Closed | -$292K |
|
|
83
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
| – | – |
-27,672
| Closed | -$1.26M |
|
Similar funds
AI
M
AWG
SC
AVLSA
AT
MTWSIF
VH
Vision Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Vision Capital Management held 83 positions worth $360M, up 13% from $317M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Vision Capital Management's Q1 2019 filing shows 7 new, 38 increased, 28 reduced and 3 closed positions. Its largest new stake was Amgen: 7,929 shares worth $1.51M. The largest sale was AbbVie, an estimated $4.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Vision Capital Management's largest Q1 2019 buy was Amgen: 7,929 shares worth $1.51M.
- Vision Capital Management added most to Vanguard FTSE Developed Markets ETF in Q1 2019, an estimated $4.29M increase.
- Vision Capital Management's biggest Q1 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.06M.
- Vision Capital Management fully exited AbbVie in Q1 2019, selling an estimated $4.5M.
- Vision Capital Management's ten largest holdings make up 48% of its $360M portfolio in Q1 2019.
- Vision Capital Management opened 7 new positions and closed 3 in Q1 2019.
- Vision Capital Management's portfolio value rose 13% quarter-over-quarter to $360M.
Based on Vision Capital Management's 13F filing for Q1 2019, filed 1 May 2019.